Moore’s Law — the idea that speed and power are always improving at an exponential pace in technology — is commonly accepted in the tech world. But does the idea translate to older, regulated industries such as pharma?
Maybe not. Michelle Crouthamel, project manager of GlaxoSmithKline’s (GSK) mHealth unit, encouraged pharma-focused tech to “slow down to match big pharma’s pace,” at a recent New York Academy of Science meeting on mHealth and wearable devices. (more…)
There were several big headlines that caught our eye last week. On the tech side, there was more promising news in the home-based healthcare front, new devices released in the “brain training” industry and plenty of funding raised by startups.
In Christian Stammel’s NYAS talk about wearable tech’s impact on the healthcare market, he gave an overview of the wearables market as well as his take on what’s coming next. Many of the devices he mentioned are consumer-grade, but it gives a peek at what’s possible for clinical trial tools.
For snazzy watch owners unwilling to part with their timepiece, new devices enable a normal watch to function as a smart device. A number of different options exist in the form of a small disc that attaches to the back of a watch, or a smart watch band. The features and metrics gathered vary with the device, but they can monitor activity and heart rates and pair with a smartphone app to provide alerts and other functions just like the Vivofits and Fitbits of the world. (more…)
If you think wearable devices are just another tech fad that will go the way of AskJeeves and 3D televisions, think again. Wearable Technologies CEO Christian Stammel says wearables are “just one piece of the whole Internet of Things phenomenon.”
Stammel recently spoke about the wearables market and what’s coming next at the NYAS meeting about wearables devices in clinical trials. We’ll be covering his talk about what wearable tech means to the healthcare market in two posts. We’re obviously most interested in what wearables can do for clinical trials, but some context on wearables as a whole can be useful in looking at what will come next for mHealth trials. (more…)
If you think video games are therapeutic and should be covered by your insurance company, there was promising news out last week. Two startups have developed video games intended to help people suffering from mental illnesses and are looking for FDA approval to market them as medical therapies.
In other news last week, we also shared a couple articles arguing about the need for pooling data as a means to finding new medical cures, and a story about a mechanical heart (that will replace a biological heart) seeking FDA approval to market it for wide-scale use. (more…)
Speaking at our recent NYAS conference on mHealth and wearable devices, John Mastrototaro, vice president of informatics at device company Medtronic, shared his futuristic views of how he believes technology and data will overhaul the healthcare system via increases in home-based patient monitoring.
Mastrototaro envisions remote monitoring and sensing will be key to a less-expensive healthcare system. (more…)
Clinical trials are often criticized for being behind the times, and neurologists working with epilepsy patients aren’t an exception. Neurologist John Hixon recently spoke at the NYAS conference, and reflected on the current system and opportunities in mHealth.
Epilepsy patients in clinical trials often use a “self report” system that depends on patients to recognize their seizures and log the events in a paper diary at a later time. The process often leads to “the parking lot effect” with patients filling out diaries in the parking lot outside of their doctor’s office before an appointment. (more…)
A few of our favorite stories last week included some great news on the mHealth and Big Data front, a smart medicine bottle that reminds patients to take prescriptions and an exoskeleton being developed for paralyzed patients.
It’s been almost a year since Medidata announced the acquisition of Patient Profiles. I sat down with Barbara Elashoff, a former FDA statistical reviewer, who along with her husband Michael, developed the Patient Profiles tool, to talk about how Patient Profiles and Centralized Statistical Analytics (CSA) has been integrated into the Medidata Clinical Cloud® and where she sees the tool will head. (more…)
Significant inefficiencies remain in the pharma industry, and pharma companies can look closely at available data to create value – starting with how to determine the feasibility of a new clinical trial.
Robert Califf, the FDA commissioner nominee, has spoken in recent months about using available data to improve the clinical trials process. “Improving the quality and efficiency of clinical trials will leverage improvements in many other aspects of the healthcare system. The only way we can get there is to use integrated information,” Califf said at a Tufts Center for Drug Development event in May. [Disclosure: I was a speaker at the event.] (more…)
Big data was big news last week, with predictions estimating that it may eventually decrease healthcare costs by $400 billion while improving patient outcomes. Based on early victories in applying big data analysis to reduce costs, experts estimate that big data has the potential to decrease healthcare costs between 12% and 17%, leading to savings in the billions. (more…)
Some of the statistics and data entered in clinical trials are more appropriate for the cover of National Enquirer than a scientific study. Can you imagine a three-foot long newborn baby? And the idea of 75 drinks a week also may raise some eyebrows. But these are just a couple of the real life examples of the freakish data errors that can slip between the cracks in clinical trials. (more…)
- Hearables, Wristables and Eyewearables!
- A Three-foot Long Baby… and Other Scary Data Errors in Clinical Trials
- How Wearables and Mobile Health Tech Are Reshaping Clinical Trials
- Providing Clarity on the Definitions of Source Data Verification (SDV) and Source Data Review (SDR)
- Tech: A Catalyst to Bring Change to Clinical Research
Moore’s Law — the idea that spe ...Nov. 23 Media Roundup
There were several big headlines th ...Hearables, Wristables and Eyewearab ...
In Christian Stammel’s NYAS talk ...Are Wearables the Next Beepers?
If you think wearable devices are j ...Nov. 16 Media Roundup
If you think video games are therap ...
Mining Clinicaltrials.gov for mHealth Data
Hi, guys. Thanks for the great post. I wonder if calling these "Industry Sponsored Mobile Health Trials" is blending a...
A Three-foot Long Baby… and Other Scary Data Errors in Clinical Trials
Brilliant angle on the benefits of RBM!
An Easy Problem to Solve: Speeding Up Payments to Clinical Trial Sites
Speaking for over 2,600 sites SCRS robustly supports this movement! You say sponsors want to keep sites - pay...
Taking ePRO to New Places – Replacing Paper
CDISC and Industry Standards
Clinical Data Analytics
Clinical Study Design
Clinical Trial Budgeting
Clinical Trial Management
Clinical Trial Phases
Cloud Computing, SaaS and PaaS
ePRO and mHealth
FDA and Regulatory Affairs
Innovation and Entrepreneurship
Interoperability and eClinical
Randomization and Clinical Trial Supply
Security and Confidentiality
Site Engagement and Monitoring
Technology and Agile Development